Poseida Therapeutics Inc

NASDAQ:PSTX 4:00:00 PM EDT

2.16

0.00 (+0.23%)

4:14:24 PM EDT: $2.16 0.00 (0.00%)

Market Cap (Intraday)	208.41M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$11.67 Million
Adjusted EPS	-$0.42

See more estimates

10-Day MA	$2.31
50-Day MA	$3.14
200-Day MA	$2.68

See more pivots

Poseida Therapeutics Inc Stock, NASDAQ:PSTX

9390 Towne Centre Drive, Suite 200, San Diego, California 92121

United States of America

Phone: +1.858.779.3100

Number of Employees: 330

http://www.poseida.com

Description

Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of non-viral gene engineering technologies for the treatment of hematological malignancies and solid tumors. Its products pipeline include autologous and allogeneic chimeric antigen receptor T cell, or CAR-T. The company was founded by Eric M. Ostertag in December 2014 and is headquartered in San Diego, CA.